Huaren Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Huaren Pharmaceutical has a total shareholder equity of CN¥2.8B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 37.6%. Its total assets and total liabilities are CN¥5.0B and CN¥2.2B respectively. Huaren Pharmaceutical's EBIT is CN¥359.5M making its interest coverage ratio 6.1. It has cash and short-term investments of CN¥112.2M.
Key information
37.6%
Debt to equity ratio
CN¥1.06b
Debt
Interest coverage ratio | 6.1x |
Cash | CN¥112.16m |
Equity | CN¥2.82b |
Total liabilities | CN¥2.18b |
Total assets | CN¥5.00b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300110's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 300110's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥652.1M).
Debt to Equity History and Analysis
Debt Level: 300110's net debt to equity ratio (33.6%) is considered satisfactory.
Reducing Debt: 300110's debt to equity ratio has increased from 27.4% to 37.6% over the past 5 years.
Debt Coverage: 300110's debt is well covered by operating cash flow (33%).
Interest Coverage: 300110's interest payments on its debt are well covered by EBIT (6.1x coverage).